Skip to main content
NASDAQ:HOLX

Hologic Stock Forecast, Price & News

$63.74
+0.94 (+1.50 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$63.00
$63.93
50-Day Range
$62.80
$76.68
52-Week Range
$49.19
$85.00
Volume1.81 million shs
Average Volume2.16 million shs
Market Capitalization$16.33 billion
P/E Ratio15.18
Dividend YieldN/A
Beta1.27
30 days | 90 days | 365 days | Advanced Chart
Receive HOLX News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.


Hologic logo

About Hologic

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry X-ray apparatus & tubes
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:HOLX
CUSIP43644010
Phone508-263-2900
Employees5,814
Year Founded1985

Sales & Book Value

Annual Sales$3.78 billion
Cash Flow$4.52 per share
Book Value$10.45 per share

Profitability

Net Income$1.12 billion

Debt

Price-To-Earnings

Miscellaneous

Market Cap$16.33 billion
Next Earnings Date8/4/2021 (Estimated)
OptionableOptionable

Social Links


MarketRank

Overall MarketRank

2.27 out of 5 stars

Medical Sector

18th out of 2,044 stocks

X-Ray Apparatus & Tubes Industry

1st out of 3 stocks

Analyst Opinion: 4.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Hologic (NASDAQ:HOLX) Frequently Asked Questions

Is Hologic a buy right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Hologic stock.
View analyst ratings for Hologic
or view top-rated stocks.

What stocks does MarketBeat like better than Hologic?

Wall Street analysts have given Hologic a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Hologic wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Hologic's next earnings date?

Hologic is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Hologic
.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) released its quarterly earnings results on Wednesday, April, 28th. The medical equipment provider reported $2.59 earnings per share for the quarter, missing the Zacks' consensus estimate of $2.62 by $0.03. The medical equipment provider earned $1.54 billion during the quarter, compared to analysts' expectations of $1.54 billion. Hologic had a trailing twelve-month return on equity of 45.24% and a net margin of 29.53%. Hologic's revenue was up 103.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.57 earnings per share.
View Hologic's earnings history
.

How has Hologic's stock been impacted by COVID-19 (Coronavirus)?

Hologic's stock was trading at $43.78 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HOLX shares have increased by 45.6% and is now trading at $63.74.
View which stocks have been most impacted by COVID-19
.

What guidance has Hologic issued on next quarter's earnings?

Hologic updated its third quarter 2021 earnings guidance on Wednesday, May, 5th. The company provided earnings per share guidance of 1.000-1.150 for the period, compared to the Thomson Reuters consensus estimate of $1.830. The company issued revenue guidance of $1 billion-$1.07 billion, compared to the consensus revenue estimate of $1.29 billion.

What price target have analysts set for HOLX?

14 Wall Street analysts have issued 12-month price objectives for Hologic's stock. Their forecasts range from $64.00 to $110.00. On average, they anticipate Hologic's stock price to reach $86.53 in the next year. This suggests a possible upside of 35.8% from the stock's current price.
View analysts' price targets for Hologic
or view top-rated stocks among Wall Street analysts.

Who are Hologic's key executives?

Hologic's management team includes the following people:
  • Mr. Stephen P. MacMillan, Chairman, CEO & Pres (Age 57, Pay $4.76M) (LinkedIn Profile)
  • Ms. Karleen M. Oberton, Chief Financial Officer (Age 51, Pay $1.45M) (LinkedIn Profile)
  • Mr. John M. Griffin, Gen. Counsel (Age 60, Pay $1.38M) (LinkedIn Profile)
  • Mr. Kevin R. Thornal, Division Pres of Diagnostic Solutions (Age 47, Pay $1.88M)
  • Dr. Jay A. Stein, Co-Founder, Chairman Emeritus, CTO & Sr. VP (Age 78)
  • Mr. Michael J. Watts, VP of Investor Relations & Corp. Communications
  • Ms. Allison P. Bebo, Sr. VP of HR (Age 52) (LinkedIn Profile)
  • Mr. Jan Verstreken, Group Pres of International
  • Mr. Sanjay Prabhakaran, Regional Pres of Asia Pacific (LinkedIn Profile)
  • Ms. Monica Aguirre Berthelot, Chief of Staff

What is Steve MacMillan's approval rating as Hologic's CEO?

283 employees have rated Hologic CEO Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among Hologic's employees.

Who are some of Hologic's key competitors?

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), The Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

What is Hologic's stock symbol?

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

Who are Hologic's major shareholders?

Hologic's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.22%), Geode Capital Management LLC (2.13%), Northern Trust Corp (1.25%), Parnassus Investments CA (1.19%), Bank of New York Mellon Corp (0.80%) and Dimensional Fund Advisors LP (0.75%). Company insiders that own Hologic stock include Benjamin Jordan Cohn, Christiana Stamoulis, John M Griffin, Karleen Marie Oberton, Kevin R Thornal, Peter J Valenti III, Sally Crawford, Sean S Daugherty and Stephen P Macmillan.
View institutional ownership trends for Hologic
.

Which institutional investors are selling Hologic stock?

HOLX stock was sold by a variety of institutional investors in the last quarter, including UBS Asset Management Americas Inc., Bank of Montreal Can, Trinity Street Asset Management LLP, Mawer Investment Management Ltd., Acadian Asset Management LLC, UBS Group AG, Assenagon Asset Management S.A., and Toronto Dominion Bank. Company insiders that have sold Hologic company stock in the last year include Benjamin Jordan Cohn, Kevin R Thornal, Peter J Valenti III, Sally Crawford, and Sean S Daugherty.
View insider buying and selling activity for Hologic
or view top insider-selling stocks.

Which institutional investors are buying Hologic stock?

HOLX stock was acquired by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company, Envestnet Asset Management Inc., Geode Capital Management LLC, Los Angeles Capital Management LLC, Arrowstreet Capital Limited Partnership, JPMorgan Chase & Co., Allianz Asset Management GmbH, and Jupiter Asset Management Ltd..
View insider buying and selling activity for Hologic
or or view top insider-buying stocks.

How do I buy shares of Hologic?

Shares of HOLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hologic's stock price today?

One share of HOLX stock can currently be purchased for approximately $63.74.

How much money does Hologic make?

Hologic has a market capitalization of $16.33 billion and generates $3.78 billion in revenue each year. The medical equipment provider earns $1.12 billion in net income (profit) each year or $3.98 on an earnings per share basis.

How many employees does Hologic have?

Hologic employs 5,814 workers across the globe.

When was Hologic founded?

Hologic was founded in 1985.

What is Hologic's official website?

The official website for Hologic is www.hologic.com.

Where are Hologic's headquarters?

Hologic is headquartered at 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752.

How can I contact Hologic?

Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-263-2900 or via email at [email protected]


This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.